10-Q: Amesite Inc. Q3 2026 Earnings: Revenue Up, Losses Narrow

Amesite Inc. reported increased revenue and reduced net loss for the nine months ended March 31, 2026, while addressing Nasdaq listing compliance.

Summary

• Amesite Inc. reported net revenue of $83,332 for the three months ended March 31, 2026, an increase from $30,690 in the same period last year.
• For the nine months ended March 31, 2026, net revenue was $285,678, up from $54,700 in the prior year period.
• The company reported a net loss of $678,061 for the three months ended March 31, 2026, compared to a net loss of $663,418 for the same period in 2025.
• The net loss for the nine months ended March 31, 2026, was $2,052,875, a decrease from $2,693,100 in the prior year period.
• As of March 31, 2026, the company had $740,711 in cash, cash equivalents, and restricted cash.
• Amesite Inc. successfully regained compliance with Nasdaq's minimum stockholder equity requirement following a registered direct offering and concurrent private placements.
• The company continues to operate with substantial doubt about its ability to continue as a going concern, despite plans for future financing.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a cautiously optimistic filing, with positive revenue trends and successful Nasdaq compliance, but significant ongoing concerns regarding profitability and going concern status.

Positives

• Net revenue increased significantly year-over-year for both the three-month and nine-month periods ended March 31, 2026.
• Net loss for the nine-month period decreased by approximately $640,000 compared to the same period in the prior year.
• The company successfully closed a registered direct offering, concurrent private placement, and insider-led private placement on April 28, 2026, raising approximately $2.6 million in gross proceeds.
• Amesite Inc. has regained compliance with Nasdaq's minimum stockholder equity requirement, as confirmed by Nasdaq on May 4, 2026.

Negatives

• The company continues to incur significant net losses, with a loss of $2,052,875 for the nine months ended March 31, 2026.
• Substantial doubt exists about the company's ability to continue as a going concern, as management's plans for future financing are not deemed probable.
• Cash and cash equivalents decreased from $2,333,418 at June 30, 2025, to $640,711 at March 31, 2026.
• Deferred revenue decreased significantly from $36,745 at June 30, 2025, to $3,975 at March 31, 2026, indicating a reduction in future revenue commitments.
• One B2B customer ceased payments, leading to an allowance for doubtful accounts of $7,964.

Risks

• The company's ability to continue as a going concern is uncertain, as it has a history of net losses and negative cash flows and expects to continue incurring losses.
• Failure to maintain compliance with Nasdaq listing requirements could lead to delisting, significantly impacting liquidity, ability to raise funds, and investor interest.
• Reliance on third parties for business operations, including designers, suppliers, and partners.
• The company's ability to obtain and maintain intellectual property protection and operate without infringing on others' intellectual property rights.
• The company's ability to attract and retain qualified key management and technical personnel.
• The impact of government regulation and developments relating to competitors or the industry.
• The company's ability to deliver solutions that offer a meaningful return on investment to customers at a price point that enables profitability.

Future Outlook

The company is focused on developing its customer base and expects to continue incurring net losses and using cash in operations in the foreseeable future. Management believes it may not have sufficient cash for planned operations for the next twelve months, and plans to generate cash through financing transactions, which are subject to market conditions and not deemed probable. The company intends to use proceeds from recent offerings for working capital and general corporate purposes.

Management Comments

• "We have strongly pivoted to growing our customer base while reducing risk and losses, resulting in a larger client base, a short-term reduction in overall revenue and a dramatic reduction in cash burn."
• "Larger, cash-upfront deals were struggling to produce sustainable revenue, as administrative barriers within nonprofits, high price points set by customers, and inability or unwillingness of customers to partner with schools, businesses and other entities to purchase products hampered growth."
• "We continue to believe that AI-powered programs, priced affordably, will supplant other academic products in the mid to long term, but have defocused on securing academic customers, and are now offering solutions for the healthcare industry."
• "We have focused all new development work on delivering AI tools to markets hungry for increased capability that immediately impacts both their performance and their bottom line. The NurseMagicTM app is the first of these and has already gained traction with larger entities."

Industry Context

StockSavvy.ai notes that Amesite Inc.'s pivot towards AI-driven solutions in the healthcare industry, exemplified by the NurseMagic app, aligns with broader market trends favoring AI adoption for efficiency and performance enhancement. The company's focus on affordability and immediate impact on the bottom line is a strategic response to market demands, particularly in sectors seeking tangible ROI from technology investments.

Comparison to Industry Standards

• The company's revenue growth, while positive, is from a small base. For instance, the 172% increase in revenue for the nine months ended March 31, 2026, to $285,678, is significantly lower than the revenue generated by established AI software companies.
• The net loss of $2,052,875 for the nine months ended March 31, 2026, indicates a continued struggle for profitability, which is a common challenge for early-stage technology companies but contrasts with the profitability of mature players in the AI and healthcare technology sectors.
• The company's cash burn rate, though reduced, remains a concern. While management aims to secure further financing, companies like Salesforce or Microsoft, which have robust cash reserves and established revenue streams, do not face similar going concern issues.

Legal Proceedings

• None mentioned in the filing.

Related Party Transactions

• On April 28, 2026, approximately $0.6 million of the capital raised was invested by certain officers and directors of the Company, including the Chairman and Chief Executive Officer and another member of the Board of Directors.

Stakeholder Impact

• Shareholders: Potential for increased dilution due to ongoing need for capital raises, but also potential upside if the company achieves profitability and growth. Successful Nasdaq compliance reduces immediate delisting risk.
• Employees: Continued employment is dependent on the company's ability to secure funding and achieve operational stability. Stock-based compensation remains a component of their remuneration.
• Creditors: The company's going concern status raises concerns about its ability to meet future obligations, though recent capital raises may alleviate immediate short-term risks.
• Customers: The company's focus on AI-driven solutions for healthcare and other sectors aims to provide value, but operational stability is crucial for long-term service delivery.

Next Steps

• Continue to focus on delivering AI tools to markets with high demand for increased capability.
• Monitor compliance with Nasdaq listing requirements, as failure to evidence compliance in the next periodic report could lead to delisting.
• Seek to complete further financing transactions to ensure sufficient cash for planned operations.
• Utilize net proceeds from recent offerings for working capital and general corporate purposes.

Key Dates

Recommendation

Amesite Inc. shows positive revenue momentum and has successfully navigated Nasdaq listing requirements through recent capital raises. However, the persistent net losses, substantial doubt about its ability to continue as a going concern, and reliance on future financing introduce significant risk. The company's strategic pivot to AI in healthcare is promising, but its execution and path to profitability remain uncertain. Therefore, a 'hold' recommendation is appropriate for investors who can tolerate high risk and are monitoring the company's progress towards sustainable operations.

Keywords

Amesite Inc., Form 10-Q, Quarterly Report, AI solutions, NurseMagic, Financial Statements, Results of Operations, Going Concern, Nasdaq Compliance, Capital Raise